Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.44 | N/A |
| PEG Ratio (TTM) | 5.90 | N/A |
| P/S Ratio (TTM) | 2.02 | N/A |
| P/B Ratio (TTM) | 2.72 | N/A |
| P/FCF Ratio (TTM) | 23.81 | N/A |
| Price to 5YR AVG Earnings Ratio | 21.34 | N/A |
| Price to 5YR AVG FCF Ratio | 17.11 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.17% | N/A |
| ROE (TTM) | 16.36% | N/A |
| Net Profit Margin (TTM) | 11.60% | N/A |
| ROIC 5YR AVG | 23.56% | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.04% | 8.99% | 6.22% |
| Revenue | 0.77% | 4.81% | 3.81% |
| Net Income | 2.66% | 5.59% | 3.35% |
| Cash Flow | 75.24% | 1.35% | -0.46% |
Health (89%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.23 | N/A |
| Quick Ratio (TTM) | 2.23 | N/A |
| D/E Ratio (TTM) | 0.10 | N/A |
| Interest Coverage (TTM) | 64.37 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 6.82 | N/A |
| LTL to 5YR AVG FCF | 0.49 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.80% | N/A |